UB Paderborn / Katalog / Suche / in CDI

Transthyretin amyloid polyneuropathy in France: A cross-sectional study with 413 patients and real-world tafamidis meglumine use (2009–2019)

Revue neurologique, 2024-04

2024

Link zum Volltext

Verfügbarkeit prüfen

Predicting mortality factors in advanced cardiac AL Amyloidosis: Prospective cohort study to improve cardiac stratification

Archives of cardiovascular diseases, 2024-01, Vol.117 (1), p.S49

2024

Link zum Volltext

Verfügbarkeit prüfen

Prevalence and prognosis of cardiac and extra-cardiac disorders in older and geriatric patients with transthyretin cardiomyopathy

Archives of cardiovascular diseases, 2024-01, Vol.117 (1), p.S37-S38

2024

Link zum Volltext

Verfügbarkeit prüfen

Les amyloses cardiaques : état des lieux en 2022

La revue de medecine interne, 2022-09, Vol.43 (9), p.537-544

2022

Link zum Volltext

Verfügbarkeit prüfen

Amylose cardiaque à transthyrétine une maladie du XXIe siècle : du diagnostic au traitement

Bulletin de l'Académie nationale de médecine, 2023-05, Vol.207 (5), p.576-582

2023

Link zum Volltext

Verfügbarkeit prüfen

Amylo-AFFECT-QOL, a self-reported questionnaire to assess health-related quality of life and to determine the prognosis in cardiac amyloidosis

Archives of cardiovascular diseases, 2024-01, Vol.117 (1), p.S39-S40

2024

Link zum Volltext

Verfügbarkeit prüfen

Pratiques actuelles et accès à la scintigraphie cardiaque avec traceurs osseux pour la détection de l’amylose cardiaque dans l’enquête nationale DIAM-ATTR

Médecine nucléaire : imagerie fonctionelle et métabolique, 2024-03, Vol.48 (2), p.58-58

2024

Link zum Volltext

Verfügbarkeit prüfen

Cardiac amyloidosis: State of art in 2022

La revue de medecine interne, 2022-09, Vol.43 (9), p.537-544

2022

Link zum Volltext

Verfügbarkeit prüfen

Evaluating the current physicians’ knowledge and patients’ pathways for diagnosing transthyretin cardiac amyloidosis (ATTR-CM) in France: An extensive survey of diverse medical specialists

Archives of cardiovascular diseases, 2024-01, Vol.117 (1), p.S38

2024

Link zum Volltext

Verfügbarkeit prüfen

Contribution of the left atrioventricular coupling index in the prediction of atrial fibrillation in cardiac amyloidosis ATTR

Archives of cardiovascular diseases, 2024-01, Vol.117 (1), p.S51

2024

Link zum Volltext

Verfügbarkeit prüfen

Traitements cardiologiques et spécifiques de l’amylose cardiaque

Archives des maladies du coeur et des vaisseaux. Pratique, 2022-02, Vol.2022 (305), p.18-22

2022

Link zum Volltext

Verfügbarkeit prüfen

Prevalence and prognostic value of autonomic neuropathy assessed by Sudoscan® in transthyretin wild‐type cardiac amyloidosis

ESC Heart Failure, 2021-04, Vol.8 (2), p.1656-1665

2021

Link zum Volltext

Verfügbarkeit prüfen

Frailty in ATTRwt Cardiac Amyloidosis: The hidden part of the iceberg

Archives of cardiovascular diseases supplements, 2021-01, Vol.13 (1), p.28-29

2021

Link zum Volltext

Verfügbarkeit prüfen

Validation of Amylo-AFFECT, a self-reported questionnaire to assess health-related quality of life and to determine the prognosis in cardiac amyloidosis

Archives of cardiovascular diseases supplements, 2023-01, Vol.15 (1), p.39

2023

Link zum Volltext

Verfügbarkeit prüfen

Homozygote and heterozygote transthyretin p.Val142Ile (V122I) genetic variant: Comparison of cardiac involvement, extracardiac manifestations and outcomes

Archives of cardiovascular diseases supplements, 2023-01, Vol.15 (1), p.36-37

2023

Link zum Volltext

Verfügbarkeit prüfen

Real-life evaluation of an algorithm for the diagnosis of cardiac amyloidosis

Archives of cardiovascular diseases supplements, 2023-01, Vol.15 (1), p.34

2023

Link zum Volltext

Verfügbarkeit prüfen

Prevalence and prognostic value of small fiber neuropathy assessed by Sudoscan ® in transthyretin wild-type cardiac amyloidosis

Archives of cardiovascular diseases supplements, 2021-01, Vol.13 (1), p.29

2021

Link zum Volltext

Verfügbarkeit prüfen

Prevalence and determinant of iron deficiency in the three main types of cardiac amyloidosis

Archives of cardiovascular diseases supplements, 2022-01, Vol.14 (1), p.34

2022

Link zum Volltext

Verfügbarkeit prüfen

Natural history and impact of treatment with tafamidis on major cardiovascular outcome-free survival time in a cohort of patients with transthyretin amyloidosis

Archives of cardiovascular diseases supplements, 2021-01, Vol.13 (1), p.27-28

2021

Link zum Volltext

Verfügbarkeit prüfen

Prevalence and type of first amyloid extracardiac symptoms and cardiac disorders history and time from their occurrence to diagnosis between Al and transthyretin cardiac amyloidosis

Archives of cardiovascular diseases supplements, 2021-01, Vol.13 (1), p.30

2021

Link zum Volltext

Verfügbarkeit prüfen

PS1410 DARATUMUMAB IS WELL TOLERATED AND INDUCES A RAPID HEMATOLOGICAL RESPONSE IN NON IG‐M LIGHT CHAIN AMYLOIDOSIS WITH SEVERE CARDIAC IMPAIRMENT

HemaSphere, 2019-06, Vol.3 (S1), p.648-n/a

2019

Link zum Volltext

Verfügbarkeit prüfen

Effect on mortality of combined or sequential chemotherapy in patients with cardiac light-chain amyloidosis

Archives of cardiovascular diseases supplements, 2019-01, Vol.11 (1), p.44-45

2019

Link zum Volltext

Verfügbarkeit prüfen

The challenge of managing patients with light-chain cardiac amyloidosis: the value of cardiac magnetic resonance as a guide to the treatment response

European heart journal, 2022-12, Vol.43 (45), p.4736-4738

2022

Link zum Volltext

Verfügbarkeit prüfen

La raison des rosomanes. Les sciences naturelles dans le Journal des Roses à la fin du XIX e siècle

Romantisme, 2020-11, Vol.n° 190 (4), p.64-78

Oghina-Pavie, Cristiana

2020

Link zum Volltext

Verfügbarkeit prüfen

La raison des rosomanes. Les sciences naturelles dans le Journal des Roses à la fin du XIXe siècle

Romantisme, 2020, Vol.190 (4), p.64-78

Oghina-Pavie, Cristiana

2020

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Transthyretin amyloid polyneuropathy in France: A cross-sectional study with 413 patients and real-world tafamidis meglumine use (2009–2019)

Predicting mortality factors in advanced cardiac AL Amyloidosis: Prospective cohort study to improve cardiac stratification

Prevalence and prognosis of cardiac and extra-cardiac disorders in older and geriatric patients with transthyretin cardiomyopathy

Les amyloses cardiaques : état des lieux en 2022

Amylose cardiaque à transthyrétine une maladie du XXIe siècle : du diagnostic au traitement

Amylo-AFFECT-QOL, a self-reported questionnaire to assess health-related quality of life and to determine the prognosis in cardiac amyloidosis

Pratiques actuelles et accès à la scintigraphie cardiaque avec traceurs osseux pour la détection de l’amylose cardiaque dans l’enquête nationale DIAM-ATTR

Cardiac amyloidosis: State of art in 2022

Evaluating the current physicians’ knowledge and patients’ pathways for diagnosing transthyretin cardiac amyloidosis (ATTR-CM) in France: An extensive survey of diverse medical specialists

Contribution of the left atrioventricular coupling index in the prediction of atrial fibrillation in cardiac amyloidosis ATTR

Traitements cardiologiques et spécifiques de l’amylose cardiaque

Prevalence and prognostic value of autonomic neuropathy assessed by Sudoscan® in transthyretin wild‐type cardiac amyloidosis

Frailty in ATTRwt Cardiac Amyloidosis: The hidden part of the iceberg

Validation of Amylo-AFFECT, a self-reported questionnaire to assess health-related quality of life and to determine the prognosis in cardiac amyloidosis

Homozygote and heterozygote transthyretin p.Val142Ile (V122I) genetic variant: Comparison of cardiac involvement, extracardiac manifestations and outcomes

Real-life evaluation of an algorithm for the diagnosis of cardiac amyloidosis

Prevalence and prognostic value of small fiber neuropathy assessed by Sudoscan ® in transthyretin wild-type cardiac amyloidosis

Prevalence and determinant of iron deficiency in the three main types of cardiac amyloidosis

Natural history and impact of treatment with tafamidis on major cardiovascular outcome-free survival time in a cohort of patients with transthyretin amyloidosis

Prevalence and type of first amyloid extracardiac symptoms and cardiac disorders history and time from their occurrence to diagnosis between Al and transthyretin cardiac amyloidosis

PS1410 DARATUMUMAB IS WELL TOLERATED AND INDUCES A RAPID HEMATOLOGICAL RESPONSE IN NON IG‐M LIGHT CHAIN AMYLOIDOSIS WITH SEVERE CARDIAC IMPAIRMENT

Effect on mortality of combined or sequential chemotherapy in patients with cardiac light-chain amyloidosis

The challenge of managing patients with light-chain cardiac amyloidosis: the value of cardiac magnetic resonance as a guide to the treatment response

La raison des rosomanes. Les sciences naturelles dans le Journal des Roses à la fin du XIX e siècle

La raison des rosomanes. Les sciences naturelles dans le Journal des Roses à la fin du XIXe siècle

Suchergebnisse filtern